PCN163 Funding by SHAs for Rarer Cancers in England: Key Success Factors in the Uptake of Cancer Drugs Fund

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.1263
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn239 - Nice and the Cancer Drugs Fund: Appraising Treatments for Rarer Cancers in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Potential Impact of the Cancer Drugs Fund Reform on Orphan Cancers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pcn305 - Nice and the Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions in Oncology?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs

JAMA network open
Medicine
2019English

Key Success Factors for Entrepreneurs in the Healthcare Business of Thailand

The EUrASEANs: journal on global socio-economic dynamics
2018English

Key Success Factors for Regenerative Medicine in Acquired Heart Diseases

Stem Cell Reviews and Reports
Cancer ResearchCell Biology
2020English

Cutbacks at England's Cancer Drugs Fund

Cancer Discovery
Oncology
2015English

Key Success Factors of Information Systems Security

Journal of Information and Organizational Sciences
Computer Science ApplicationsInformation SystemsLibraryInformation Sciences
2019English

Key Factors for Project Crowdfunding Success: An Empirical Study

Sustainability
DevelopmentManagementMonitoringEnvironmental ScienceRenewable EnergyEnergy EngineeringLawSustainabilityPlanningPolicyPower Technologythe EnvironmentGeography
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy